FeaturedFeatured EUScience & Research CTF CEO Annette Bakker Moderates Panel at World Orphan Drug Congress 2025
CTF in the NewsFeaturedFeatured EUScience & Research How a Once-Abandoned Drug Found New Life – and Changed the Future for NF Patients
Awards & GrantsFeaturedFeatured EUNF1Science & Research Young Investigator: Q&A with Sarah Morrow about NF1 and MPNST
AdvocacyFeaturedFeatured EU Children’s Tumor Foundation Chair Pens Message Urging Restoration of NF Research Funding
AdvocacyAwarenessFeaturedFeatured EUPharma From NF to the World: Rare Disease Day and the Race for Faster Treatments
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaPress ReleaseScience & Research Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of NF1
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaPress ReleaseScience & Research CureAge Therapeutics Launches to Advance Genetic Therapies for Neurofibromatosis
Awards & GrantsFeaturedFeatured EUNF1Science & Research Young Investigator: Q&A with Alex Dyson about NF1 and brain mechanisms
AwarenessFeaturedFeatured EU Good2Give Podcast: Understanding and Combating NF: Insights from the Children’s Tumor Foundation